Abstract
Common practice is to withhold vaccination with live-attenuated vaccines in patients with rheumatic diseases on high-dose DMARDs, glucocorticosteroids or biological agents, due to limited safety data, and the risk of introducing an infectious disease to the patient. Evidence for this approach is low. We collected data from pediatric rheumatologists who regularly have vaccinated these patients, to obtain additional safety data, which might update and revise such approach. Data from 13 pediatric rheumatology centers in 10 countries were collected and herein discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 178-179 |
| Number of pages | 2 |
| Journal | Annals of the Rheumatic Diseases |
| DOIs | |
| Publication status | Published - 2019 |
| Event | EULAR European Congress of Rheumatology - MADRID Duration: 12 Jun 2019 → 15 Jun 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Vaccinations
Fingerprint
Dive into the research topics of 'Live attenuated vaccines in pediatric rheumatic diseases are safe: multicenter retrospective data collection.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver